Stock Price Forecast

April 26, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading ARDELYX, INC. chart...

About the Company

We do not have any company description for ARDELYX, INC. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

200

Exchange

Nasdaq

$17M

Total Revenue

200

Employees

$1B

Market Capitalization

-25.55

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ARDX News

Ardelyx, Inc. (ARDX)

2d ago, source: Yahoo Finance

Conference call scheduled for 4:30 p.m. Eastern TimeWALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover ...

Ardelyx's (NASDAQ:ARDX) investors will be pleased with their favorable 91% return over the last five years

4d ago, source:

While Ardelyx, Inc. ( NASDAQ:ARDX ) shareholders are probably generally happy, the stock hasn't had particularly ...

Ardelyx Stock Collapses After FDA Rejects Its Kidney Disease Candidate Pitch

20d ago, source: AOL

Three months after revealing that the FDA had asked for more information to support tenapanor application for a chronic kidney disease drug, the FDA issued a letter to Ardelyx Inc (NASDAQ ...

Ardelyx gets grant for compound inhibiting enzyme 11-HSD2 for treating hyperkalemia

5d ago, source: Pharmaceutical Technology

Discover how Ardelyx Inc's patented compound inhibits 11-HSD2 enzyme, treating hyperkalemia by stimulating potassium excretion. Learn about the formula, variations, and potential medical applications ...

A Closer Look at 6 Analyst Recommendations For Ardelyx

23d ago, source: Business Insider

Delving into Ardelyx's Background Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant ...

Ardelyx, Inc. (41X.F)

1mon ago, source: Yahoo Finance

Ardelyx, Inc. (NASDAQ:ARDX) Q4 2023 Earnings Call Transcript February 22, 2024 Ardelyx, Inc. misses on earnings expectations. Reported EPS is $-0.12 EPS, expectations were $-0.09. Ardelyx, Inc. isn’t ...

Ardelyx, Inc. Reports Employment Inducement Grants

1mon ago, source: Finanznachrichten

Zeit Aktuelle Nachrichten 05.04. A Closer Look at 6 Analyst Recommendations For Ardelyx 28.03. Ardelyx, Inc. Reports Employment Inducement Grants WALTHAM, Mass., March 28, 2024 (GLOBE NEWSWIRE ...

Ardelyx Inc

11d ago, source: U.S. News & World Report

Invest with your heart and your phone with as little as $1 with these ESG and socially responsible investing apps.

Ardelyx, Inc. Reports Employment Inducement Grants

1mon ago, source: ADVFN

Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical ...

Ardelyx, Inc. Reports Employment Inducement Grants

1mon ago, source: Yahoo Finance

WALTHAM, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...